Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - TOTAL EQUITY
Total Equity AKBA - Akebia Therapeutics, Inc.
-30.6 M
LAST VALUE
-18.32%
2 YEAR CAGR
-0.94%
5 YEAR CAGR
-7.15%
10 YEAR CAGR